Notably, the combination of doxorubicin and melatonin showed a better efficacy than doxorubicin alone in inducing apoptosis, mitochondrial membrane depolarization, and caspase 3 and 9 activation in MCF-7 human breast cancer cells (Koşar et al., 2016). Here, CASP3 is linked to breast carcinoma.